Drug-Resistant Infections in the Community:Consequences for Public Health
The full committee held a hearing to examine the public health consequences of infections of methicillin-resistant Staphylococcus aureus (MRSA) outside of hospitals and other healthcare settings, including the measures people can take to reduce the risk of MRSA infections and what these infections tell us about the public health challenges in addressing such infections. A transcript of this hearing is now available.
The following witnesses testified:
Panel I:
Dr. Julie Louise Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention
Panel II:
Dr. James Burns, M.D., M.B.A., Chief Deputy Commissioner for Public Health, Virginia Department of Health, Richmond, Virginia
Dr. Elizabeth A. Bancroft, M.D., S.M., Medical Epidemiologist, Los Angeles County Department of Health Services, Los Angeles, California
Dr. Robert S. Daum, M.D., Professor of Pediatrics, University of Chicago, Chicago, Illinois
Mr. Steven L. Walts, Ed.D., Superintendent of Schools, Prince William County Schools, Manassas, Virginia
Dr. Eric Gale, M.D., Bronx Regional Medical Director, Institute for Family Health